Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis.
Overview
- Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center,Columbus, OH USA
- Center for Biostatistics, The Ohio State University Wexner Medical Center,Columbus, OH USA
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center,Columbus, OH USA
Abstract
Purpose: Breast cancer (BC) brain metastases (BM) treatment involves radiotherapy (RT), surgery, and CNS-penetrating systemic therapies. This study evaluated treatment patterns in brain RT and corresponding survival outcomes among patients with BC BM using the National Cancer Database (NCDB).
Methods: Patients diagnosed with BC BM between 2010 and 2021 were identified. RT was categorized as whole brain (WBRT) vs. stereotactic (SRT). We fitted Overlap Propensity Score Weighting (OPSW) Cox models to account for confounders affecting OS. Variables included age, race, ethnicity, Charlson–Deyo score, insurance, molecular subtype, facility type, and systemic therapy.
Results: Of 8909 patients with BC BM, 43.4% received brain RT (74.1% WBRT, 25.9% SRT). Patients that are African American, lower income, urban, triple-negative, or at community facilities were more likely to receive WBRT over SRT (p < 0.05). Median OS for the entire cohort was 10.9 months (95% CI 10.4–11.5). Systemic therapy alone (HR 0.40, 95% CI 0.36–0.43) or combined with RT (HR 0.38, 95% CI 0.35–0.42) improved OS; however RT alone did not improve survival on MVA (HR 0.96 (95% CI 0.91–1.02). Among RT recipients, SRT was associated with improved OS vs. WBRT (HR 0.76, 95% CI 0.69–0.83). Older age, comorbidities, lack of insurance, community facilities, and aggressive subtypes were associated with worse OS.
Conclusions: Treatment patterns, particularly access to SRT, differ among BC BM patients therefore highlighting the need for strategies to promote equitable implementation of evidence-based guidelines. More prospective trials are also needed to establish evidence-based treatment standards for BC BM.
Supplementary Information: The online version contains supplementary material available at 10.1007/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data availability
Data are available in the National Cancer Database (NCDB) upon request at https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 22 authors, 5 keywords, 11 MeSH terms, 23 references.
Cite
This paper
Pathmarajah, T., Gokun, Y., Williams, N., Sizemore, G. M., Lefebvre, H., Gatti-Mays, M. E., Slover, B., Daniel, S., Jitwatcharakomol, T., Eckstein, J., Andraos, T., Young, R., Grecula, J., Raval, R., Singh, R., Zhu, S., Blakaj, D., Chakravarti, A., Palmer, J., . . . Beyer, S. (2026). Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis. Breast cancer research and treatment, 217(2), 26. https://
BibTeX
@article{pathmarajah2026
author = {Pathmarajah, Thamilini and Gokun, Yevgeniya and Williams, Nicole and Sizemore, Gina M. and Lefebvre, Heather and Gatti-Mays, Margaret E. and Slover, Brandon and Daniel, Sierra and Jitwatcharakomol, Tanun and Eckstein, Jacob and Andraos, Therese and Young, Rebekah and Grecula, John and Raval, Raju and Singh, Raj and Zhu, Simeng and Blakaj, Dukajin and Chakravarti, Arnab and Palmer, Joshua and Stover, Daniel and Jhawar, Sachin R. and Beyer, Sasha},
title = {{Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis}},
journal = {Breast cancer research and treatment},
year = {2026},
month = apr,
volume = {217},
number = {2},
pages = {26},
publisher = {Springer Science+Business Media},
issn = {0167-6806},
doi = {10.1007/
url = {https://
pmid = {42018017},
pmcid = {PMC13102853}
}
RIS
TY - JOUR
AU - Pathmarajah, Thamilini
AU - Gokun, Yevgeniya
AU - Williams, Nicole
AU - Sizemore, Gina M.
AU - Lefebvre, Heather
AU - Gatti-Mays, Margaret E.
AU - Slover, Brandon
AU - Daniel, Sierra
AU - Jitwatcharakomol, Tanun
AU - Eckstein, Jacob
AU - Andraos, Therese
AU - Young, Rebekah
AU - Grecula, John
AU - Raval, Raju
AU - Singh, Raj
AU - Zhu, Simeng
AU - Blakaj, Dukajin
AU - Chakravarti, Arnab
AU - Palmer, Joshua
AU - Stover, Daniel
AU - Jhawar, Sachin R.
AU - Beyer, Sasha
TI - Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis
T2 - Breast cancer research and treatment
J2 - Breast Cancer Res Treat
PY - 2026
DA - 2026/
VL - 217
IS - 2
SP - 26
SN - 0167-6806
PB - Springer Science+Business Media
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis",
"container-title": "Breast cancer research and treatment",
"author": [
{
"family": "Pathmarajah",
"given": "Thamilini"
},
{
"family": "Gokun",
"given": "Yevgeniya"
},
{
"family": "Williams",
"given": "Nicole"
},
{
"family": "Sizemore",
"given": "Gina M."
},
{
"family": "Lefebvre",
"given": "Heather"
},
{
"family": "Gatti-Mays",
"given": "Margaret E."
},
{
"family": "Slover",
"given": "Brandon"
},
{
"family": "Daniel",
"given": "Sierra"
},
{
"family": "Jitwatcharakomol",
"given": "Tanun"
},
{
"family": "Eckstein",
"given": "Jacob"
},
{
"family": "Andraos",
"given": "Therese"
},
{
"family": "Young",
"given": "Rebekah"
},
{
"family": "Grecula",
"given": "John"
},
{
"family": "Raval",
"given": "Raju"
},
{
"family": "Singh",
"given": "Raj"
},
{
"family": "Zhu",
"given": "Simeng"
},
{
"family": "Blakaj",
"given": "Dukajin"
},
{
"family": "Chakravarti",
"given": "Arnab"
},
{
"family": "Palmer",
"given": "Joshua"
},
{
"family": "Stover",
"given": "Daniel"
},
{
"family": "Jhawar",
"given": "Sachin R."
},
{
"family": "Beyer",
"given": "Sasha"
}
],
"container-title-short":
"volume": "217",
"issue": "2",
"page": "26",
"DOI": "10.1007/
"PMID": "42018017",
"PMCID": "PMC13102853",
"ISSN": "0167-6806",
"publisher": "Springer Science+Business Media",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1080/14796694.2025.2470604
- TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases.Journal: Future oncology (London, England)In common: clinical / translational, other condition, 3 references
- [2] doi:10.1158/2159-8290.cd-22-0837
- Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.Journal: Cancer discoveryIn common: clinical / translational, other condition, 3 references
- [3] doi:10.1093/oncolo/oyac064
- Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.Journal: The oncologistIn common: clinical / translational, other condition, 3 references
- [4] doi:10.1016/j.phro.2024.100602
- Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery.Journal: Physics and imaging in radiation oncologyIn common: clinical / translational, other condition, 3 references
- [5] doi:10.5306/wjco.v14.i11.445
- Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.Journal: World journal of clinical oncologyIn common: clinical / translational, other condition, 2 references
- [6] doi:10.1159/000552141
- Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review.Journal: Case reports in oncologyIn common: clinical / translational, other condition, 2 references
- [7] doi:10.1007/s00259-025-07118-0
- A hybrid [&
lt;sup& gt;18& lt;/ sup& gt;F]fluoropivalate PET-multiparametric MRI to detect and characterise brain tumour metastases based on a permissive environment for monocarboxylate transport. Journal: European journal of nuclear medicine and molecular imagingIn common: clinical / translational, other condition, 2 references - [8] doi:10.3389/fonc.2025.1497195 [code]
- Early characterization and prediction of glioblastoma and brain metastasis treatment efficacy using medical imaging-based radiomics and artificial intelligence algorithms.Journal: Frontiers in oncologyIn common: clinical / translational, other condition, 2 references
- [9] doi:10.1186/s40478-025-02001-3 [code]
- Genomic and immune profiling of breast cancer brain metastases.Journal: Acta neuropathologica communicationsIn common: other condition, 2 references
- [10] doi:10.1158/0008-5472.can-25-4018 [code]
- MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders.Journal: Cancer researchIn common: other condition, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
